224 related articles for article (PubMed ID: 9649149)
1. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
[TBL] [Abstract][Full Text] [Related]
2. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
[TBL] [Abstract][Full Text] [Related]
3. Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.
Okabe-Kado J; Kasukabe T; Honma Y
Leuk Lymphoma; 1998 Dec; 32(1-2):19-28. PubMed ID: 10036998
[TBL] [Abstract][Full Text] [Related]
4. Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia.
Yokoyama A; Okabe-Kado J; Sakashita A; Maseki N; Kaneko Y; Hino K; Tomoyasu S; Tsuruoka N; Kasukabe T; Honma Y
Blood; 1996 Nov; 88(9):3555-61. PubMed ID: 8896423
[TBL] [Abstract][Full Text] [Related]
5. [Expression of nm23 genes in acute myeloid leukemia and its clinical significance].
Meng QX; Jiang R; Yang BQ; Zhang HY; Liu J; Pang LP; Wang J
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):369-71. PubMed ID: 12941193
[TBL] [Abstract][Full Text] [Related]
6. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
Okabe-Kado J
Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
Blood; 2000 Aug; 96(3):1080-6. PubMed ID: 10910925
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of differentiation inhibitory factor nm23 mRNA in monoblastic crisis of a patient with chronic myelogenous leukemia.
Wakimoto N; Yokoyama A; Mukai Y; Kuwada N; Yamashita T; Matsumura T; Nakamura Y; Kanatani Y; Nagata N; Okabe-Kado J; Honma Y; Motoyoshi K
Int J Hematol; 1998 Apr; 67(3):313-8. PubMed ID: 9650453
[TBL] [Abstract][Full Text] [Related]
9. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.
Martinez JA; Prevot S; Nordlinger B; Nguyen TM; Lacarriere Y; Munier A; Lascu I; Vaillant JC; Capeau J; Lacombe ML
Gut; 1995 Nov; 37(5):712-20. PubMed ID: 8549951
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome.
Ito Y; Okabe-Kado J; Honma Y; Iwase O; Shimamoto T; Ohyashiki JH; Ohyashiki K
Leukemia; 2002 Feb; 16(2):165-9. PubMed ID: 11840281
[TBL] [Abstract][Full Text] [Related]
13. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.
Aryee DN; Simonitsch I; Mosberger I; Kos K; Mann G; Schlögl E; Pötschger U; Gadner H; Radaszkiewicz T; Kovar H
Br J Cancer; 1996 Dec; 74(11):1693-8. PubMed ID: 8956779
[TBL] [Abstract][Full Text] [Related]
14. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of nm23 protein expression in renal cell carcinomas.
Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
[TBL] [Abstract][Full Text] [Related]
16. nm23-H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome.
Guo X; Min HQ; Zeng MS; Qian CN; Huang XM; Shao JY; Hou JH
Int J Cancer; 1998 Dec; 79(6):596-600. PubMed ID: 9842967
[TBL] [Abstract][Full Text] [Related]
17. Expression of nm23/NDP kinase proteins on the cell surface.
Urano T; Furukawa K; Shiku H
Oncogene; 1993 May; 8(5):1371-6. PubMed ID: 8386830
[TBL] [Abstract][Full Text] [Related]
18. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma.
Yamaguchi A; Urano T; Goi T; Takeuchi K; Niimoto S; Nakagawara G; Furukawa K; Shiku H
Cancer; 1994 May; 73(9):2280-4. PubMed ID: 8168032
[TBL] [Abstract][Full Text] [Related]
19. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.
Konishi N; Nakaoka S; Tsuzuki T; Matsumoto K; Kitahori Y; Hiasa Y; Urano T; Shiku H
Jpn J Cancer Res; 1993 Oct; 84(10):1050-4. PubMed ID: 7693635
[TBL] [Abstract][Full Text] [Related]
20. High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance.
Aryee DN; Ströbel T; Kos K; Salzer-Kuntschik M; Zoubek A; Veron M; Ambros IM; Traincart F; Gadner H; Kovar H
Int J Cancer; 1995 Apr; 64(2):104-11. PubMed ID: 7542225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
